Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-25-009840
Filing Date
2025-03-28
Accepted
2025-03-28 16:03:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A aytu20250318_defa14a.htm DEFA14A 10764
2 ab01.jpg GRAPHIC 241802
3 ab02.jpg GRAPHIC 185972
  Complete submission text file 0001437749-25-009840.txt   601216
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-38247 | Film No.: 25785856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)